Sana Biotechnology: A Shot At Diabetes

Sana Biotechnology, a biotech company, has announced a collaboration with Vertex Pharmaceuticals to develop a gene therapy for type 1 diabetes. The therapy aims to restore insulin production in patients.

The partnership is significant in the global biotech industry and could potentially impact the lives of millions of people worldwide living with type 1 diabetes.